Healthtech funding in 2025
European Healthtech startup funding raised during 2025.
In 2025, 424 European Healthtech companies closed 439 funding rounds and raised €7.5B in equity funding (excluding debt and grants). Debt rounds added €146M. UK led by capital raised, and Venture Kick was the most active investor. Data as of 18 Nov 2026.
Equity funding
€7.5B
excl. debt & grants · +€146M debt
Funding rounds
439
Companies
424
Top country
UK
Healthtech: last three years
change vs the year beforeRank among sectors
#3
10.7% of sector funding
Debt financing
€146M
1.9% of total
Top-10 round share
39.9%
of disclosed capital
Rounds ≥ €100M
15
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, 2025 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jan | €1.5B | 35 |
| Feb | €214M | 44 |
| Mar | €804M | 33 |
| Apr | €427M | 39 |
| May | €739M | 47 |
| Jun | €360M | 41 |
| Jul | €420M | 43 |
| Aug | €514M | 23 |
| Sep | €537M | 44 |
| Oct | €1.7B | 47 |
| Nov | €442M | 26 |
| Dec | €128M | 17 |
Top countries
by € raisedHealthtech — top countries by capital, 2025 — interactive chart.
Data table
| Healthtech — top countries by capital, 2025 | |
|---|---|
| UK | €2.5B |
| Switzerland | €1.1B |
| Finland | €881M |
| Germany | €770M |
| Netherlands | €479M |
| Spain | €396M |
| Sweden | €374M |
| France | €353M |
Stage mix
by € raisedHealthtech — stage mix, 2025 — interactive chart.
Data table
| Healthtech — stage mix, 2025 | |
|---|---|
| Other | €2.6B |
| Series A | €1.6B |
| Series B | €1.3B |
| Series D+ | €1.1B |
| Series C | €552M |
| Seed | €278M |
| Debt | €146M |
| Grant | €98M |
| Pre-Seed | €43M |
| Growth/Late | €26M |
| Early VC | €2.1M |
| Crowdfunding | €460k |
Exits & M&A
29 Acquisition · 1 IPO30 exits · €9.3B disclosed.
| Merus | Acquisition | Sep 2025 | €6.8B |
| Vicebio | Acquisition | Jul 2025 | €1.4B |
| Imcheck Therapeutics | Acquisition | Oct 2025 | €1.0B |
| Pharvaris | IPO | Jul 2025 | €172M |
Largest equity rounds
by disclosed amount, 2025| Company | Stage | Date | Amount |
|---|---|---|---|
| Oura Health | Series D+ | Oct 2025 | €774M |
| Isomorphic Labs | Other | Mar 2025 | €555M |
| Verdiva Bio | Series A | Jan 2025 | €399M |
| Tubulis Technologies | Series C | Oct 2025 | €308M |
| Neko Health | Series B | Jan 2025 | €250M |
| Ortivity | Other | Aug 2025 | €200M |
| CMR Surgical | Other | Apr 2025 | €185M |
| Cera | Other | Jan 2025 | €150M |
| Azafaros | Series B | May 2025 | €132M |
| DistalMotion | Series D+ | Nov 2025 | €130M |
Largest debt rounds
debt financing, 2025; not in the equity total| Company | Stage | Date | Amount |
|---|---|---|---|
| Oculis | Debt | Aug 2025 | €106M |
| Overture Life | Debt | Nov 2025 | €20M |
| Leyden Labs | Debt | Jun 2025 | €20M |
| DigeHealth | Debt | May 2025 | €107k |
Top investors
most active in 2025, by deal count- Venture Kick12 deals
- Bayern Kapital8 deals
- EQT Life Sciences8 deals
- Sofinnova Partners8 deals
- Bpifrance7 deals
- High-Tech Gründerfonds (HTGF)7 deals
- Novo Holdings7 deals
- YZR Capital7 deals
- European Innovation Council (EIC)6 deals
- LocalGlobe6 deals
Source: Tech.eu Funding Explorer · data as of 18 Nov 2026 · licence CC BY 4.0 · Methodology